Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs Endoscopy for Primary Prophylaxis of Variceal Bleeding
NCT02695732Phase 4Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol in esophageal and gastric varices (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Bleeding rate at 18 months. Status: unknown.
02
Drugs
carvedilol
03
Conditions
esophageal and gastric varices
Beyond the preview
Go deeper on NCT02695732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695732.